Cyclosporine a loaded PLGA nanoparticles for dry eye disease: In vitro characterization studies

Journal of Nanotechnology

Volumn 2014, Issue , 2014, Pages

  Wagh, Vijay D ^a   Apar, Dipak U ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMERS; EVAPORATION; NANOPARTICLES; PARTICLE SIZE; ZETA POTENTIAL;

ENTRAPMENT EFFICIENCY; FRANZ DIFFUSION CELLS; MEAN PARTICLE SIZE; NANOPARTICLE (NPS); OPHTHALMIC DELIVERY; POLY(DL-LACTIDE-COGLYCOLIDE); SOLVENT EVAPORATION TECHNIQUES; SURFACE CHARACTERISTICS;

DRUG PRODUCTS;

EID: 84896110371     PISSN: 16879503     EISSN: 16879511     Source Type: Journal    
DOI: 10.1155/2014/683153     Document Type: Article

References (34)

1. Wagh V. D., Apar D. U., Surana S. J., Drug delivery and pharmacotherapy for dry eye disease. International Journal of Pharmacy and Pharmaceutical Sciences 2012 4 2 42 46 2-s2.0-84859949340
2. Wagh V. D., Apar D. U., Surana S. J., Animal models of dry eye disease: a review. Journal of Pharmaceutical Sciences and Research 2012 4 3 1758 1760 2-s2.0-84859304996
3. Pflugfelder S. C., Antiinflammatory therapy for dry eye. The American Journal of Ophthalmology 2004 137 2 337 342 10.1016/j.ajo.2003.10.036 (Pubitemid 38221009)
4. Pflugfelder S. C., Solomon A., Stern M. E., The diagnosis and management of dry eye: a twenty-five-year review. Cornea 2000 19 5 644 649 2-s2.0-0033822741 10.1097/00003226-200009000-00009
5. Stern M. E., Gao J., Siemasko K. F., Beuerman R. W., Pflugfelder S. C., The role of the lacrimal functional unit in the pathophysiology of dry eye. Experimental Eye Research 2004 78 3 409 416 2-s2.0-0842331882 10.1016/j.exer.2003.09.003 (Pubitemid 38183319)
6. Behrens A., Doyle J. J., Stern L., Chuck R. S., McDonnell P. J., Azar D. T., Dua H. S., Hom M., Karpecki P. M., Laibson P. R., Lemp M. A., Meisler D. M., Castillo J. M. D., O'Brien T. P., Pflugfelder S. C., Rolando M., Schein O. D., Seitz B., Tseng S. C., Setten G. V., Wilson S. E., Yiu S. C., Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006 25 8 900 907 2-s2.0-33750366586 10.1097/01.ico.0000214802.40313.fa (Pubitemid 44763848)
7. Zu Q., Kambhampati S. P., Kannan R. M., Nanotechnology approaches for ocular drug delivery. Middle East African Journal of Ophthalmology 2013 20 1 26 37 10.4103/0974-9233.106384
8. McCabe E., Narayanan S., Advancements in anti-inflammatory therapy for dry eye syndrome. Optometry 2009 80 10 555 566 2-s2.0-70349433591 10.1016/j.optm.2009.02.010
9. Belin M. W., Bouchard C. S., Phillips T. M., Update on topical cyclosporin A: background, immunology, and pharmacology. Cornea 1990 9 3 184 195 2-s2.0-0024991478 (Pubitemid 20298629)
10. Schreiber S. L., Crabtree G. R., The mechanism of action of cyclosporin A and FK506. Immunology Today 1992 13 4 136 142 2-s2.0-0026575932 10.1016/0167-5699(92)90111-J
11. Mundargi R. C., Babu V. R., Rangaswamy V., Patel P., Aminabhavi T. M., Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Journal of Controlled Release 2008 125 3 193 209 2-s2.0-38349154138 10.1016/j.jconrel.2007.09.013
12. Chaturvedi K., Ganguly K., Kulkarni A. R., Kulkarni V. H., Nadagouda M. N., Rudzinski W. E., Aminabhavi T. M., Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review. Expert Opinion on Drug Delivery 2011 8 11 1455 1468 2-s2.0-80054809662 10.1517/17425247.2011.610790
13. Calvo P., Thomas C., Alonso M. J., Vila-Jato J. L., Robinson J. R., Study of the mechanism of interaction of poly(ε -caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy. International Journal of Pharmaceutics 1994 103 3 283 291 2-s2.0-0028268115 10.1016/0378-5173(94)90179-1
14. Soppimath K. S., Aminabhavi T. M., Kulkarni A. R., Rudzinski W. E., Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 2001 70 1-2 1 20 2-s2.0-0035966497 10.1016/S0168-3659(00) 00339-4 (Pubitemid 32144788)
15. Mainardes R. M., Urban M. C. C., Cinto P. O., Khalil N. M., Chaud M. V., Evangelista R. C., Gremião M. P. D., Colloidal carriers for ophthalmic drug delivery. Current Drug Targets 2005 6 3 363 371 2-s2.0-18744409539 10.2174/1389450053765914 (Pubitemid 40667801)
16. Guinedi A. S., Mortada N. D., Mansour S., Hathout R. M., Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. International Journal of Pharmaceutics 2005 306 1-2 71 82 2-s2.0-27844529489 10.1016/j.ijpharm.2005.09.023 (Pubitemid 41643141)
17. Patravale V. B., Date Abhijit A., Kulkarni R. M., Nanosuspensions: a promising drug delivery strategy. Journal of Pharmacy and Pharmacology 2004 56 7 827 840 2-s2.0-3042814562 10.1211/0022357023691 (Pubitemid 38885975)
18. Vega E., Gamisans F., García M. L., Chauvet A., Lacoulonche F., Egea M. A., PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. Journal of Pharmaceutical Sciences 2008 97 12 5306 5317 2-s2.0-57349134515 10.1002/jps.21383
19. Araújo J., Vega E., Lopes C., Egea M. A., Garcia M. L., Souto E. B., Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids and Surfaces B 2009 72 1 48 56 2-s2.0-67349194262 10.1016/j.colsurfb.2009.03.028
20. Dillen K., Vandervoort J., van den Mooter G., Ludwig A., Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. International Journal of Pharmaceutics 2006 314 1 72 82 2-s2.0-33646536352 10.1016/j.ijpharm.2006.01.041
21. Dillen K., Bridts C., van der Veken P., Cos P., Vandervoort J., Augustyns K., Stevens W., Ludwig A., Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas. International Journal of Pharmaceutics 2008 349 1-2 234 240 2-s2.0-37449031598 10.1016/j.ijpharm.2007.07.041
22. Costa P., Sousa Lobo J. M., Modeling and comparison of dissolution profiles. The European Journal of Pharmaceutical Sciences 2001 13 2 123 133 2-s2.0-0035073301 10.1016/S0928-0987(01)00095-1 (Pubitemid 32288781)
23. Dai J., Nagai T., Wang X., Zhang T., Meng M., Zhang Q., pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. International Journal of Pharmaceutics 2004 280 1-2 229 240 2-s2.0-3242673239 10.1016/j.ijpharm.2004.05.006 (Pubitemid 38950919)
24. Quintanar-Guerrero D., Allémann E., Fessi H., Doelker E., Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Development and Industrial Pharmacy 1998 24 12 1113 1128 2-s2.0-0345084474 10.3109/03639049809108571 (Pubitemid 28546092)
25. Vauthier-Holtzscherer C., Benabbou S., Spenlehauer G., Veillard M., Couvreur P., Methodology for the preparation of ultra-dispersed polymer systems. STP Pharma Sciences 1991 1 2 109 116 2-s2.0-0025731687
26. Jaiswal J., Gupta S. K., Kreuter J., Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. Journal of Controlled Release 2004 96 1 169 178 2-s2.0-1842525943 10.1016/j.jconrel.2004.01.017 (Pubitemid 38438499)
27. Nkabinde L. A., Shoba-Zikhali L. N., Semete-Makokotlela B., Kalombo L., Swai H. S., Hayeshi R., Naicker B., Hillie T. K., Hamman J. H., Permeation of PLGA nanoparticles across different in vitro models. Current Drug Delivery 2012 9 6 617 627 10.2174/156720112803529819
28. Filho J. T. S., Portugal R. D., Loureiro M., Pulcheri W., Nucci M., Characterization and analysis of the outcome of adults with acute myeloid leukemia treated in a Brazilian University hospital over three decades. The Brazilian Journal of Medical and Biological Research 2011 44 7 660 665 2-s2.0-79961096384 10.1590/S0100-879X2011000700008
29. Hoffart V., Ubrich N., Simonin C., Babak V., Vigneron C., Hoffman M., Lecompte T., Maincent P., Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics. Drug Development and Industrial Pharmacy 2002 28 9 1091 1099 2-s2.0-0036411727 10.1081/DDC-120014576 (Pubitemid 35278833)
30. Vandervoort J., Yoncheva K., Ludwig A., Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. Chemical and Pharmaceutical Bulletin 2004 52 11 1273 1279 2-s2.0-21644471608 10.1248/cpb.52.1273 (Pubitemid 41364442)
31. Zhang D., Tan T., Gao L., Zhao W., Wang P., Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies. Drug Development and Industrial Pharmacy 2007 33 5 569 575 2-s2.0-34249323769 10.1080/03639040600975147 (Pubitemid 46808766)
32. Kondo M., Niwa T., Okamoto H., Danjo K., Particle characterization of poorly water-soluble drugs using a spray freeze drying technique. Chemical and Pharmaceutical Bulletin 2009 57 7 657 662 2-s2.0-67650806122 10.1248/cpb.57.657
33. Aksungur P., Demirbilek M., Denkbaş E. B., Vandervoort J., Ludwig A., Ünlü N., Development and characterization of cyclosporine A loaded nanoparticles for ocular drug delivery: cellular toxicity, uptake, and kinetic studies. Journal of Controlled Release 2011 151 3 286 294 2-s2.0-79957490620 10.1016/j.jconrel.2011.01.010
34. He Y., Liu Y., Liu Y., Wang J., Zhang X., Lu W., Ma Z., Zhu X., Zhang Q., Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study. Investigative Ophthalmology and Visual Science 2006 47 9 3983 3988 2-s2.0-33749124756 10.1167/iovs.05-1373 (Pubitemid 46044315)